{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T02:51:05Z","timestamp":1792291865223,"version":"4.4.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,12,18]],"date-time":"2021-12-18T00:00:00Z","timestamp":1639785600000},"content-version":"vor","delay-in-days":17,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Insights Imaging"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>This review aims to identify factors causing heterogeneity in breast DWI\u2013MRI and their impact on its value for identifying breast cancer patients with pathological complete response (pCR) on neoadjuvant systemic therapy (NST). A search was performed on PubMed until April 2020 for studies analyzing DWI for identifying breast cancer patients with pCR on NST. Technical and clinical study aspects were extracted and assessed for variability. Twenty studies representing 1455 patients\/lesions were included. The studies differed with respect to study population, treatment type, DWI acquisition technique, post-processing (e.g., mono-exponential\/intravoxel incoherent motion\/stretched exponential modeling), and timing of follow-up studies. For the acquisition and generation of ADC-maps, various <jats:italic>b<\/jats:italic>-value combinations were used. Approaches for drawing regions of interest on longitudinal MRIs were highly variable. Biological variability due to various molecular subtypes was usually not taken into account. Moreover, definitions of pCR varied. The individual areas under the curve for the studies range from 0.50 to 0.92. However, overlapping ranges of mean\/median ADC-values at pre- and\/or during and\/or post-NST were found for the pCR and non-pCR groups between studies. The technical, clinical, and epidemiological heterogeneity may be causal for the observed variability in the ability of DWI to predict pCR accurately. This makes implementation of DWI for pCR prediction and evaluation based on one absolute ADC threshold for all breast cancer types undesirable. Multidisciplinary consensus and appropriate clinical study design, taking biological and therapeutic variation into account, is required for obtaining standardized, reliable, and reproducible DWI measurements for pCR\/non-pCR identification.\n<\/jats:p>","DOI":"10.1186\/s13244-021-01123-1","type":"journal-article","created":{"date-parts":[[2021,12,18]],"date-time":"2021-12-18T11:14:26Z","timestamp":1639826066000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Factors affecting the value of diffusion-weighted imaging for identifying breast cancer patients with pathological complete response on neoadjuvant systemic therapy: a systematic review"],"prefix":"10.1186","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8521-817X","authenticated-orcid":false,"given":"Kay J. J.","family":"van der Hoogt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Schipper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gonneke A.","family":"Winter-Warnars","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leon C.","family":"ter Beek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudette E.","family":"Loo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritse M.","family":"Mann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regina G. H.","family":"Beets-Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,12,18]]},"reference":[{"issue":"2","key":"1123_CR1","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.ejso.2018.09.027","volume":"45","author":"PER Spronk","year":"2019","unstructured":"Spronk PER, Volders JH, van den Tol P, Smorenburg CH, Vrancken Peeters M (2019) Breast conserving therapy after neoadjuvant chemotherapy; data from the Dutch Breast Cancer Audit. Eur J Surg Oncol 45(2):110\u2013117. https:\/\/doi.org\/10.1016\/j.ejso.2018.09.027","journal-title":"Eur J Surg Oncol"},{"issue":"3","key":"1123_CR2","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/s10549-018-4801-3","volume":"170","author":"W Haque","year":"2018","unstructured":"Haque W, Verma V, Hatch S, Suzanne Klimberg V, Brian Butler E, Teh BS (2018) Response rates and pathologic complete response by breast cancer molecular subtype following neoadjuvant chemotherapy. Breast Cancer Res Treat 170(3):559\u2013567. https:\/\/doi.org\/10.1007\/s10549-018-4801-3","journal-title":"Breast Cancer Res Treat"},{"issue":"29","key":"1123_CR3","doi-asserted-by":"publisher","first-page":"4218","DOI":"10.3748\/wjg.v26.i29.4218","volume":"26","author":"F L\u00f3pez-Campos","year":"2020","unstructured":"L\u00f3pez-Campos F, Mart\u00edn-Mart\u00edn M, Fornell-P\u00e9rez R et al (2020) Watch and wait approach in rectal cancer: current controversies and future directions. World J Gastroenterol 26(29):4218\u20134239. https:\/\/doi.org\/10.3748\/wjg.v26.i29.4218","journal-title":"World J Gastroenterol"},{"key":"1123_CR4","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.breast.2018.04.018","volume":"40","author":"H Li","year":"2018","unstructured":"Li H, Yao L, Jin P et al (2018) MRI and PET\/CT for evaluation of the pathological response to neoadjuvant chemotherapy in breast cancer: a systematic review and meta-analysis. Breast 40:106\u2013115. https:\/\/doi.org\/10.1016\/j.breast.2018.04.018","journal-title":"Breast"},{"issue":"11","key":"1123_CR5","doi-asserted-by":"publisher","first-page":"4786","DOI":"10.1007\/s00330-017-4831-y","volume":"27","author":"F Tian","year":"2017","unstructured":"Tian F, Shen G, Deng Y, Diao W, Jia Z (2017) The accuracy of (18)F-FDG PET\/CT in predicting the pathological response to neoadjuvant chemotherapy in patients with breast cancer: a meta-analysis and systematic review. Eur Radiol 27(11):4786\u20134796. https:\/\/doi.org\/10.1007\/s00330-017-4831-y","journal-title":"Eur Radiol"},{"issue":"3","key":"1123_CR6","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1245\/s10434-015-4918-0","volume":"23","author":"B Schaefgen","year":"2016","unstructured":"Schaefgen B, Mati M, Sinn HP et al (2016) Can routine imaging after neoadjuvant chemotherapy in breast cancer predict pathologic complete response? Ann Surg Oncol 23(3):789\u2013795. https:\/\/doi.org\/10.1245\/s10434-015-4918-0","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"1123_CR7","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1200\/JCO.2010.31.1258","volume":"29","author":"CE Loo","year":"2011","unstructured":"Loo CE, Straver ME, Rodenhuis S et al (2011) Magnetic resonance imaging response monitoring of breast cancer during neoadjuvant chemotherapy: relevance of breast cancer subtype. J Clin Oncol 29(6):660\u2013666. https:\/\/doi.org\/10.1200\/JCO.2010.31.1258","journal-title":"J Clin Oncol"},{"issue":"7","key":"1123_CR8","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/S1474-4422(17)30158-8","volume":"16","author":"V Gulani","year":"2017","unstructured":"Gulani V, Calamante F, Shellock FG, Kanal E, Reeder SB, International Society for Magnetic Resonance in Medicine (2017) Gadolinium deposition in the brain: summary of evidence and recommendations. Lancet Neurol 16(7):564\u2013570. https:\/\/doi.org\/10.1016\/S1474-4422(17)30158-8","journal-title":"Lancet Neurol"},{"key":"1123_CR9","doi-asserted-by":"publisher","DOI":"10.1002\/jmri.26908","author":"M Iima","year":"2019","unstructured":"Iima M, Honda M, Sigmund EE, Ohno Kishimoto A, Kataoka M, Togashi K (2019) Diffusion MRI of the breast: current status and future directions. J Magn Reson Imaging. https:\/\/doi.org\/10.1002\/jmri.26908","journal-title":"J Magn Reson Imaging"},{"issue":"2","key":"1123_CR10","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1593\/neo.81328","volume":"11","author":"AR Padhani","year":"2009","unstructured":"Padhani AR, Liu G, Koh DM et al (2009) Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia 11(2):102\u2013125","journal-title":"Neoplasia"},{"issue":"7","key":"1123_CR11","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.mri.2005.11.005","volume":"24","author":"MD Pickles","year":"2006","unstructured":"Pickles MD, Gibbs P, Lowry M, Turnbull LW (2006) Diffusion changes precede size reduction in neoadjuvant treatment of breast cancer. Magn Reson Imaging 24(7):843\u2013847. https:\/\/doi.org\/10.1016\/j.mri.2005.11.005","journal-title":"Magn Reson Imaging"},{"issue":"6","key":"1123_CR12","doi-asserted-by":"publisher","first-page":"7088","DOI":"10.18632\/oncotarget.23195","volume":"9","author":"W Chu","year":"2018","unstructured":"Chu W, Jin W, Liu D et al (2018) Diffusion-weighted imaging in identifying breast cancer pathological response to neoadjuvant chemotherapy: a meta-analysis. Oncotarget 9(6):7088\u20137100. https:\/\/doi.org\/10.18632\/oncotarget.23195","journal-title":"Oncotarget"},{"issue":"1","key":"1123_CR13","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s12957-018-1438-y","volume":"16","author":"W Gao","year":"2018","unstructured":"Gao W, Guo N, Dong T (2018) Diffusion-weighted imaging in monitoring the pathological response to neoadjuvant chemotherapy in patients with breast cancer: a meta-analysis. World J Surg Oncol 16(1):145. https:\/\/doi.org\/10.1186\/s12957-018-1438-y","journal-title":"World J Surg Oncol"},{"key":"1123_CR14","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-019-06510-3","author":"P Baltzer","year":"2019","unstructured":"Baltzer P, Mann RM, Iima M et al (2019) Diffusion-weighted imaging of the breast-a consensus and mission statement from the EUSOBI International Breast Diffusion-Weighted Imaging working group. Eur Radiol. https:\/\/doi.org\/10.1007\/s00330-019-06510-3","journal-title":"Eur Radiol"},{"issue":"8","key":"1123_CR15","doi-asserted-by":"publisher","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","volume":"155","author":"PF Whiting","year":"2011","unstructured":"Whiting PF, Rutjes AW, Westwood ME et al (2011) QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 155(8):529\u2013536. https:\/\/doi.org\/10.7326\/0003-4819-155-8-201110180-00009","journal-title":"Ann Intern Med"},{"issue":"3","key":"1123_CR16","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1002\/jmri.24843","volume":"42","author":"S Liu","year":"2015","unstructured":"Liu S, Ren R, Chen Z et al (2015) Diffusion-weighted imaging in assessing pathological response of tumor in breast cancer subtype to neoadjuvant chemotherapy. J Magn Reson Imaging 42(3):779\u2013787. https:\/\/doi.org\/10.1002\/jmri.24843","journal-title":"J Magn Reson Imaging"},{"issue":"5","key":"1123_CR17","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.clbc.2015.02.002","volume":"15","author":"E Bufi","year":"2015","unstructured":"Bufi E, Belli P, Costantini M et al (2015) Role of the apparent diffusion coefficient in the prediction of response to neoadjuvant chemotherapy in patients with locally advanced breast cancer. Clin Breast Cancer 15(5):370\u2013380. https:\/\/doi.org\/10.1016\/j.clbc.2015.02.002","journal-title":"Clin Breast Cancer"},{"issue":"1","key":"1123_CR18","doi-asserted-by":"publisher","first-page":"16372","DOI":"10.1038\/s41598-019-52785-3","volume":"9","author":"NP Pereira","year":"2019","unstructured":"Pereira NP, Curi C, Osorio C et al (2019) Diffusion-weighted magnetic resonance imaging of patients with breast cancer following neoadjuvant chemotherapy provides early prediction of pathological response\u2014a prospective study. Sci Rep 9(1):16372. https:\/\/doi.org\/10.1038\/s41598-019-52785-3","journal-title":"Sci Rep"},{"issue":"4","key":"1123_CR19","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000002420","volume":"95","author":"S Che","year":"2016","unstructured":"Che S, Zhao X, Ou Y et al (2016) Role of the intravoxel incoherent motion diffusion weighted imaging in the pre-treatment prediction and early response monitoring to neoadjuvant chemotherapy in locally advanced breast cancer. Medicine (Baltimore) 95(4):e2420. https:\/\/doi.org\/10.1097\/MD.0000000000002420","journal-title":"Medicine (Baltimore)"},{"issue":"7","key":"1123_CR20","doi-asserted-by":"publisher","first-page":"2726","DOI":"10.1007\/s00330-016-4630-x","volume":"27","author":"R Bedair","year":"2017","unstructured":"Bedair R, Priest AN, Patterson AJ et al (2017) Assessment of early treatment response to neoadjuvant chemotherapy in breast cancer using non-mono-exponential diffusion models: a feasibility study comparing the baseline and mid-treatment MRI examinations. Eur Radiol 27(7):2726\u20132736. https:\/\/doi.org\/10.1007\/s00330-016-4630-x","journal-title":"Eur Radiol"},{"issue":"4","key":"1123_CR21","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s10334-017-0610-7","volume":"30","author":"F Gallivanone","year":"2017","unstructured":"Gallivanone F, Panzeri MM, Canevari C et al (2017) Biomarkers from in vivo molecular imaging of breast cancer: pretreatment (18)F-FDG PET predicts patient prognosis, and pretreatment DWI-MR predicts response to neoadjuvant chemotherapy. MAGMA 30(4):359\u2013373. https:\/\/doi.org\/10.1007\/s10334-017-0610-7","journal-title":"MAGMA"},{"issue":"1","key":"1123_CR22","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s40644-018-0173-5","volume":"18","author":"L Yuan","year":"2018","unstructured":"Yuan L, Li JJ, Li CQ et al (2018) Diffusion-weighted MR imaging of locally advanced breast carcinoma: the optimal time window of predicting the early response to neoadjuvant chemotherapy. Cancer Imaging 18(1):38. https:\/\/doi.org\/10.1186\/s40644-018-0173-5","journal-title":"Cancer Imaging"},{"issue":"3","key":"1123_CR23","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1148\/radiol.2018180273","volume":"289","author":"SC Partridge","year":"2018","unstructured":"Partridge SC, Zhang Z, Newitt DC et al (2018) Diffusion-weighted MRI findings predict pathologic response in neoadjuvant treatment of breast cancer: the ACRIN 6698 multicenter trial. Radiology 289(3):618\u2013627. https:\/\/doi.org\/10.1148\/radiol.2018180273","journal-title":"Radiology"},{"issue":"10","key":"1123_CR24","doi-asserted-by":"publisher","first-page":"909.e907","DOI":"10.1016\/j.crad.2018.05.026","volume":"73","author":"D Zhang","year":"2018","unstructured":"Zhang D, Zhang Q, Suo S et al (2018) Apparent diffusion coefficient measurement in luminal breast cancer: will tumour shrinkage patterns affect its efficacy of evaluating the pathological response? Clin Radiol 73(10):909.e907\u2013909.e914. https:\/\/doi.org\/10.1016\/j.crad.2018.05.026","journal-title":"Clin Radiol"},{"issue":"2","key":"1123_CR25","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.acra.2017.08.009","volume":"25","author":"YA Ramirez-Galvan","year":"2018","unstructured":"Ramirez-Galvan YA, Cardona-Huerta S, Elizondo-Riojas G, Alvarez-Villalobos NA (2018) Apparent diffusion coefficient value to evaluate tumor response after neoadjuvant chemotherapy in patients with breast cancer. Acad Radiol 25(2):179\u2013187. https:\/\/doi.org\/10.1016\/j.acra.2017.08.009","journal-title":"Acad Radiol"},{"issue":"12","key":"1123_CR26","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1002\/nbm.2807","volume":"25","author":"HJ Shin","year":"2012","unstructured":"Shin HJ, Baek HM, Ahn JH et al (2012) Prediction of pathologic response to neoadjuvant chemotherapy in patients with breast cancer using diffusion-weighted imaging and MRS. NMR Biomed 25(12):1349\u20131359. https:\/\/doi.org\/10.1002\/nbm.2807","journal-title":"NMR Biomed"},{"issue":"3","key":"1123_CR27","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1148\/radiol.2016160176","volume":"283","author":"G Santamaria","year":"2017","unstructured":"Santamaria G, Bargallo X, Fernandez PL, Farrus B, Caparros X, Velasco M (2017) Neoadjuvant systemic therapy in breast cancer: association of contrast-enhanced MR imaging findings, diffusion-weighted imaging findings, and tumor subtype with tumor response. Radiology 283(3):663\u2013672. https:\/\/doi.org\/10.1148\/radiol.2016160176","journal-title":"Radiology"},{"key":"1123_CR28","doi-asserted-by":"publisher","DOI":"10.1002\/jmri.26518","author":"A Shukla-Dave","year":"2018","unstructured":"Shukla-Dave A, Obuchowski NA, Chenevert TL et al (2018) Quantitative imaging biomarkers alliance (QIBA) recommendations for improved precision of DWI and DCE-MRI derived biomarkers in multicenter oncology trials. J Magn Reson Imaging. https:\/\/doi.org\/10.1002\/jmri.26518","journal-title":"J Magn Reson Imaging"},{"key":"1123_CR29","unstructured":"QIBA Diffusion-Weighted Imaging MR Biomarker Committee Diffusion-Weighted Magnetic Resonance Imaging. Quantitative Imaging Biomarkers Alliance. http:\/\/qibawiki.rsna.org\/index.php\/Profiles."},{"issue":"3","key":"1123_CR30","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1002\/jmri.25664","volume":"46","author":"W Wu","year":"2017","unstructured":"Wu W, Miller KL (2017) Image formation in diffusion MRI: a review of recent technical developments. J Magn Reson Imaging 46(3):646\u2013662. https:\/\/doi.org\/10.1002\/jmri.25664","journal-title":"J Magn Reson Imaging"},{"issue":"5","key":"1123_CR31","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1002\/jmri.22562","volume":"33","author":"LR Arlinghaus","year":"2011","unstructured":"Arlinghaus LR, Welch EB, Chakravarthy AB et al (2011) Motion correction in diffusion-weighted MRI of the breast at 3\u00a0T. J Magn Reson Imaging 33(5):1063\u20131070. https:\/\/doi.org\/10.1002\/jmri.22562","journal-title":"J Magn Reson Imaging"},{"issue":"1","key":"1123_CR32","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1002\/mrm.26328","volume":"78","author":"I Hancu","year":"2017","unstructured":"Hancu I, Lee SK, Hulsey K et al (2017) Distortion correction in diffusion-weighted imaging of the breast: performance assessment of prospective, retrospective, and combined (prospective + retrospective) approaches. Magn Reson Med 78(1):247\u2013253. https:\/\/doi.org\/10.1002\/mrm.26328","journal-title":"Magn Reson Med"},{"issue":"3","key":"1123_CR33","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1002\/jmri.20683","volume":"24","author":"D Le Bihan","year":"2006","unstructured":"Le Bihan D, Poupon C, Amadon A, Lethimonnier F (2006) Artifacts and pitfalls in diffusion MRI. J Magn Reson Imaging 24(3):478\u2013488. https:\/\/doi.org\/10.1002\/jmri.20683","journal-title":"J Magn Reson Imaging"},{"key":"1123_CR34","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.ejmp.2018.09.007","volume":"55","author":"L Fedeli","year":"2018","unstructured":"Fedeli L, Belli G, Ciccarone A et al (2018) Dependence of apparent diffusion coefficient measurement on diffusion gradient direction and spatial position\u2014a quality assurance intercomparison study of forty-four scanners for quantitative diffusion-weighted imaging. Phys Med 55:135\u2013141. https:\/\/doi.org\/10.1016\/j.ejmp.2018.09.007","journal-title":"Phys Med"},{"key":"1123_CR35","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ejmp.2021.04.020","volume":"85","author":"L Fedeli","year":"2021","unstructured":"Fedeli L, Benelli M, Busoni S et al (2021) On the dependence of quantitative diffusion-weighted imaging on scanner system characteristics and acquisition parameters: a large multicenter and multiparametric phantom study with unsupervised clustering analysis. Phys Med 85:98\u2013106. https:\/\/doi.org\/10.1016\/j.ejmp.2021.04.020","journal-title":"Phys Med"},{"issue":"1","key":"1123_CR36","doi-asserted-by":"publisher","first-page":"e86280","DOI":"10.1371\/journal.pone.0086280","volume":"9","author":"M Giannelli","year":"2014","unstructured":"Giannelli M, Sghedoni R, Iacconi C et al (2014) MR scanner systems should be adequately characterized in diffusion-MRI of the breast. PLoS One 9(1):e86280. https:\/\/doi.org\/10.1371\/journal.pone.0086280","journal-title":"PLoS One"},{"issue":"6","key":"1123_CR37","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1002\/jmri.26539","volume":"49","author":"DC Newitt","year":"2019","unstructured":"Newitt DC, Zhang Z, Gibbs JE et al (2019) Test-retest repeatability and reproducibility of ADC measures by breast DWI: results from the ACRIN 6698 trial. J Magn Reson Imaging 49(6):1617\u20131628. https:\/\/doi.org\/10.1002\/jmri.26539","journal-title":"J Magn Reson Imaging"},{"issue":"5","key":"1123_CR38","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1002\/jmri.22152","volume":"31","author":"NH Peters","year":"2010","unstructured":"Peters NH, Vincken KL, van den Bosch MA, Luijten PR, Mali WP, Bartels LW (2010) Quantitative diffusion weighted imaging for differentiation of benign and malignant breast lesions: the influence of the choice of b-values. J Magn Reson Imaging 31(5):1100\u20131105. https:\/\/doi.org\/10.1002\/jmri.22152","journal-title":"J Magn Reson Imaging"},{"issue":"3","key":"1123_CR39","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1007\/s00330-016-4403-6","volume":"27","author":"MG Zeilinger","year":"2017","unstructured":"Zeilinger MG, Lell M, Baltzer PA, Dorfler A, Uder M, Dietzel M (2017) Impact of post-processing methods on apparent diffusion coefficient values. Eur Radiol 27(3):946\u2013955. https:\/\/doi.org\/10.1007\/s00330-016-4403-6","journal-title":"Eur Radiol"},{"issue":"2","key":"1123_CR40","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s11604-009-0391-7","volume":"28","author":"M Tozaki","year":"2010","unstructured":"Tozaki M, Oyama Y, Fukuma E (2010) Preliminary study of early response to neoadjuvant chemotherapy after the first cycle in breast cancer: comparison of 1H magnetic resonance spectroscopy with diffusion magnetic resonance imaging. Jpn J Radiol 28(2):101\u2013109. https:\/\/doi.org\/10.1007\/s11604-009-0391-7","journal-title":"Jpn J Radiol"},{"issue":"4","key":"1123_CR41","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1002\/jmri.25237","volume":"44","author":"KE Keenan","year":"2016","unstructured":"Keenan KE, Peskin AP, Wilmes LJ et al (2016) Variability and bias assessment in breast ADC measurement across multiple systems. J Magn Reson Imaging 44(4):846\u2013855. https:\/\/doi.org\/10.1002\/jmri.25237","journal-title":"J Magn Reson Imaging"},{"issue":"4","key":"1123_CR42","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1002\/jmri.24883","volume":"42","author":"DC Newitt","year":"2015","unstructured":"Newitt DC, Tan ET, Wilmes LJ et al (2015) Gradient nonlinearity correction to improve apparent diffusion coefficient accuracy and standardization in the American College of Radiology Imaging Network 6698 breast cancer trial. J Magn Reson Imaging 42(4):908\u2013919. https:\/\/doi.org\/10.1002\/jmri.24883","journal-title":"J Magn Reson Imaging"},{"issue":"7","key":"1123_CR43","doi-asserted-by":"publisher","first-page":"e26","DOI":"10.1002\/jmri.26598","volume":"49","author":"KE Keenan","year":"2019","unstructured":"Keenan KE, Biller JR, Delfino JG et al (2019) Recommendations towards standards for quantitative MRI (qMRI) and outstanding needs. J Magn Reson Imaging 49(7):e26\u2013e39. https:\/\/doi.org\/10.1002\/jmri.26598","journal-title":"J Magn Reson Imaging"},{"issue":"4","key":"1123_CR44","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1097\/RLI.0000000000000100","volume":"50","author":"X Li","year":"2015","unstructured":"Li X, Abramson RG, Arlinghaus LR et al (2015) Multiparametric magnetic resonance imaging for predicting pathological response after the first cycle of neoadjuvant chemotherapy in breast cancer. Invest Radiol 50(4):195\u2013204. https:\/\/doi.org\/10.1097\/RLI.0000000000000100","journal-title":"Invest Radiol"},{"key":"1123_CR45","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.ctro.2018.09.002","volume":"13","author":"S Leibfarth","year":"2018","unstructured":"Leibfarth S, Winter RM, Lyng H, Zips D, Thorwarth D (2018) Potentials and challenges of diffusion-weighted magnetic resonance imaging in radiotherapy. Clin Transl Radiat Oncol 13:29\u201337. https:\/\/doi.org\/10.1016\/j.ctro.2018.09.002","journal-title":"Clin Transl Radiat Oncol"},{"issue":"5","key":"1123_CR46","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1007\/s00330-016-4564-3","volume":"27","author":"H Bickel","year":"2017","unstructured":"Bickel H, Pinker K, Polanec S et al (2017) Diffusion-weighted imaging of breast lesions: region-of-interest placement and different ADC parameters influence apparent diffusion coefficient values. Eur Radiol 27(5):1883\u20131892. https:\/\/doi.org\/10.1007\/s00330-016-4564-3","journal-title":"Eur Radiol"},{"issue":"10","key":"1123_CR47","doi-asserted-by":"publisher","first-page":"e0138702","DOI":"10.1371\/journal.pone.0138702","volume":"10","author":"O Arponen","year":"2015","unstructured":"Arponen O, Sudah M, Masarwah A et al (2015) Diffusion-weighted imaging in 3.0 T breast MRI: diagnostic performance and tumor characterization using small subregions versus whole tumor regions of interest. PLoS One 10(10):e0138702. https:\/\/doi.org\/10.1371\/journal.pone.0138702","journal-title":"PLoS One"},{"issue":"2","key":"1123_CR48","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1097\/RCT.0b013e318246abf3","volume":"36","author":"TH Kim","year":"2012","unstructured":"Kim TH, Kang DK, Yim H, Jung YS, Kim KS, Kang SY (2012) Magnetic resonance imaging patterns of tumor regression after neoadjuvant chemotherapy in breast cancer patients: correlation with pathological response grading system based on tumor cellularity. J Comput Assist Tomogr 36(2):200\u2013206. https:\/\/doi.org\/10.1097\/RCT.0b013e318246abf3","journal-title":"J Comput Assist Tomogr"},{"issue":"5","key":"1123_CR49","doi-asserted-by":"publisher","first-page":"e0232856","DOI":"10.1371\/journal.pone.0232856","volume":"15","author":"M Wielema","year":"2020","unstructured":"Wielema M, Dorrius MD, Pijnappel RM et al (2020) Diagnostic performance of breast tumor tissue selection in diffusion weighted imaging: a systematic review and meta-analysis. PLoS One 15(5):e0232856. https:\/\/doi.org\/10.1371\/journal.pone.0232856","journal-title":"PLoS One"},{"issue":"2","key":"1123_CR50","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1148\/radiol.2020200221","volume":"297","author":"JA McKay","year":"2020","unstructured":"McKay JA, Church AL, Rubin N et al (2020) A comparison of methods for high-spatial-resolution diffusion-weighted imaging in breast MRI. Radiology 297(2):304\u2013312. https:\/\/doi.org\/10.1148\/radiol.2020200221","journal-title":"Radiology"},{"issue":"6","key":"1123_CR51","doi-asserted-by":"publisher","first-page":"3172","DOI":"10.1002\/mrm.27101","volume":"79","author":"DS Novikov","year":"2018","unstructured":"Novikov DS, Kiselev VG, Jespersen SN (2018) On modeling. Magn Reson Med 79(6):3172\u20133193. https:\/\/doi.org\/10.1002\/mrm.27101","journal-title":"Magn Reson Med"},{"key":"1123_CR52","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.breast.2016.09.015","volume":"30","author":"L Orlando","year":"2016","unstructured":"Orlando L, Viale G, Bria E et al (2016) Discordance in pathology report after central pathology review: implications for breast cancer adjuvant treatment. Breast 30:151\u2013155. https:\/\/doi.org\/10.1016\/j.breast.2016.09.015","journal-title":"Breast"},{"key":"1123_CR53","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.mri.2017.12.018","volume":"48","author":"Y Kim","year":"2018","unstructured":"Kim Y, Kim SH, Lee HW et al (2018) Intravoxel incoherent motion diffusion-weighted MRI for predicting response to neoadjuvant chemotherapy in breast cancer. Magn Reson Imaging 48:27\u201333. https:\/\/doi.org\/10.1016\/j.mri.2017.12.018","journal-title":"Magn Reson Imaging"},{"issue":"7","key":"1123_CR54","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1093\/annonc\/mdv161","volume":"26","author":"V Bossuyt","year":"2015","unstructured":"Bossuyt V, Provenzano E, Symmans WF et al (2015) Recommendations for standardized pathological characterization of residual disease for neoadjuvant clinical trials of breast cancer by the BIG-NABCG collaboration. Ann Oncol 26(7):1280\u20131291. https:\/\/doi.org\/10.1093\/annonc\/mdv161","journal-title":"Ann Oncol"},{"issue":"9","key":"1123_CR55","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1038\/modpathol.2015.74","volume":"28","author":"E Provenzano","year":"2015","unstructured":"Provenzano E, Bossuyt V, Viale G et al (2015) Standardization of pathologic evaluation and reporting of postneoadjuvant specimens in clinical trials of breast cancer: recommendations from an international working group. Mod Pathol 28(9):1185\u20131201. https:\/\/doi.org\/10.1038\/modpathol.2015.74","journal-title":"Mod Pathol"},{"issue":"9","key":"1123_CR56","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1016\/j.ejrad.2016.06.019","volume":"85","author":"M Durando","year":"2016","unstructured":"Durando M, Gennaro L, Cho GY et al (2016) Quantitative apparent diffusion coefficient measurement obtained by 3.0 T MRI as a potential noninvasive marker of tumor aggressiveness in breast cancer. Eur J Radiol 85(9):1651\u20131658. https:\/\/doi.org\/10.1016\/j.ejrad.2016.06.019","journal-title":"Eur J Radiol"},{"issue":"7","key":"1123_CR57","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1007\/s00330-012-2403-8","volume":"22","author":"L Martincich","year":"2012","unstructured":"Martincich L, Deantoni V, Bertotto I et al (2012) Correlations between diffusion-weighted imaging and breast cancer biomarkers. Eur Radiol 22(7):1519\u20131528. https:\/\/doi.org\/10.1007\/s00330-012-2403-8","journal-title":"Eur Radiol"},{"issue":"Suppl 1","key":"1123_CR58","doi-asserted-by":"publisher","first-page":"34S","DOI":"10.2967\/jnumed.115.157875","volume":"57","author":"S Avril","year":"2016","unstructured":"Avril S, Muzic RF Jr, Plecha D, Traughber BJ, Vinayak S, Avril N (2016) 18F-FDG PET\/CT for monitoring of treatment response in breast cancer. J Nucl Med 57(Suppl 1):34S-39S. https:\/\/doi.org\/10.2967\/jnumed.115.157875","journal-title":"J Nucl Med"},{"issue":"5","key":"1123_CR59","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1007\/s00330-016-4565-2","volume":"27","author":"L Minarikova","year":"2017","unstructured":"Minarikova L, Bogner W, Pinker K et al (2017) Investigating the prediction value of multiparametric magnetic resonance imaging at 3 T in response to neoadjuvant chemotherapy in breast cancer. Eur Radiol 27(5):1901\u20131911. https:\/\/doi.org\/10.1007\/s00330-016-4565-2","journal-title":"Eur Radiol"},{"issue":"4","key":"1123_CR60","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1007\/s00330-014-3487-0","volume":"25","author":"S Halligan","year":"2015","unstructured":"Halligan S, Altman DG, Mallett S (2015) Disadvantages of using the area under the receiver operating characteristic curve to assess imaging tests: a discussion and proposal for an alternative approach. Eur Radiol 25(4):932\u2013939. https:\/\/doi.org\/10.1007\/s00330-014-3487-0","journal-title":"Eur Radiol"},{"issue":"1","key":"1123_CR61","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s13244-021-00995-7","volume":"12","author":"L Mart\u00ed-Bonmat\u00ed","year":"2021","unstructured":"Mart\u00ed-Bonmat\u00ed L (2021) Evidence levels in radiology: the insights into imaging approach. Insights Imaging 12(1):45. https:\/\/doi.org\/10.1186\/s13244-021-00995-7","journal-title":"Insights Imaging"},{"issue":"3","key":"1123_CR62","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/nrclinonc.2016.162","volume":"14","author":"JP O'Connor","year":"2017","unstructured":"O\u2019Connor JP, Aboagye EO, Adams JE et al (2017) Imaging biomarker roadmap for cancer studies. Nat Rev Clin Oncol 14(3):169\u2013186. https:\/\/doi.org\/10.1038\/nrclinonc.2016.162","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"1123_CR63","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1186\/s12885-016-2653-y","volume":"16","author":"A Miquel-Cases","year":"2016","unstructured":"Miquel-Cases A, Steuten LM, Rigter LS, van Harten WH (2016) Cost-effectiveness and resource use of implementing MRI-guided NACT in ER-positive\/HER2-negative breast cancers in The Netherlands. BMC Cancer 16(1):712. https:\/\/doi.org\/10.1186\/s12885-016-2653-y","journal-title":"BMC Cancer"},{"issue":"2","key":"1123_CR64","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1148\/radiol.2542090405","volume":"254","author":"R Woodhams","year":"2010","unstructured":"Woodhams R, Kakita S, Hata H et al (2010) Identification of residual breast carcinoma following neoadjuvant chemotherapy: diffusion-weighted imaging\u2014comparison with contrast-enhanced MR imaging and pathologic findings. Radiology 254(2):357\u2013366. https:\/\/doi.org\/10.1148\/radiol.2542090405","journal-title":"Radiology"},{"issue":"6","key":"1123_CR65","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1007\/s00330-010-2020-3","volume":"21","author":"A Fangberget","year":"2011","unstructured":"Fangberget A, Nilsen LB, Hole KH et al (2011) Neoadjuvant chemotherapy in breast cancer-response evaluation and prediction of response to treatment using dynamic contrast-enhanced and diffusion-weighted MR imaging. Eur Radiol 21(6):1188\u20131199. https:\/\/doi.org\/10.1007\/s00330-010-2020-3","journal-title":"Eur Radiol"},{"issue":"6","key":"1123_CR66","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1007\/s12282-013-0449-3","volume":"21","author":"H Fujimoto","year":"2014","unstructured":"Fujimoto H, Kazama T, Nagashima T et al (2014) Diffusion-weighted imaging reflects pathological therapeutic response and relapse in breast cancer. Breast Cancer 21(6):724\u2013731. https:\/\/doi.org\/10.1007\/s12282-013-0449-3","journal-title":"Breast Cancer"},{"issue":"2","key":"1123_CR67","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.ejrad.2013.10.023","volume":"83","author":"SY Hahn","year":"2014","unstructured":"Hahn SY, Ko EY, Han BK, Shin JH, Ko ES (2014) Role of diffusion-weighted imaging as an adjunct to contrast-enhanced breast MRI in evaluating residual breast cancer following neoadjuvant chemotherapy. Eur J Radiol 83(2):283\u2013288. https:\/\/doi.org\/10.1016\/j.ejrad.2013.10.023","journal-title":"Eur J Radiol"}],"container-title":["Insights into Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13244-021-01123-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13244-021-01123-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13244-021-01123-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,18]],"date-time":"2021-12-18T11:15:13Z","timestamp":1639826113000},"score":1,"resource":{"primary":{"URL":"https:\/\/insightsimaging.springeropen.com\/articles\/10.1186\/s13244-021-01123-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":67,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1123"],"URL":"https:\/\/doi.org\/10.1186\/s13244-021-01123-1","relation":{},"ISSN":["1869-4101"],"issn-type":[{"value":"1869-4101","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"14 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors of this manuscript declare relationships with the following companies: Ritse M. Mann, MD, PhD (research agreements: Siemens Healthineers, Bayer Healthcare, ScreenPoint Medical, Seno Medical, Koning, Medtronic, BD\/Bard). All remaining authors declare no competing interest. Ritse M. Mann and Regina Beets-Tan are members of the Insights into Imaging Advisory Editorial Board. They have not taken part in the review or selection process of this article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"187"}}